Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?
Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?
复制标题
心室辅助设备：目的地治疗是非移植候选者的可行替代方案吗？
DOI：
10.1007/s11897-012-0123-7
复制
发表时间：
2013-03
影响因子：
--
通讯作者：
Lanfear, David E
中科院分区：
文献类型：
--
作者：
Hrobowski, Tara;Lanfear, David E
本文的主题，用更熟悉的方式表述，是左心室辅助装置 (LVAD) 本身是否已准备好作为一种治疗选择进入“黄金时段”。为了提供有关这个问题的最新信息和见解，我们简要回顾了该领域的发展历程，并更详细地描述了其当前状态以及我们的发展方向。我们相信这个问题的简短答案是“是”，但像许多事情一样，简短的答案是不够的。在这里，我们试图提供一个更全面的答案，提供一些历史背景，概述已经取得的巨大成就，以及在 LVAD 成为真正主流疗法之前仍然存在的许多挑战。
The topic of this article, stated a more familiar way, is whether left ventricular assist devices (LVADs) are ready for ‘Primetime’ as a therapeutic option in and of themselves. In order to provide an update and insight on this question, we briefly review from where the field has come, and in more detail describe its current state and where we are heading. We believe the short answer to this question is ‘Yes’, but like many things, a short answer is not adequate. Here we attempt to deliver a more comprehensive answer, providing some historical context, outlining the great achievements that have been made, as well as the many challenges that still remain before LVADs become a truly mainstream therapy.